Episurf Medical will exhibit at the 7th Annual Congress of the German Knee Society (DKG), held in Munich, Germany, on November 23-24
Episurf Medical (NASDAQ: EPIS B) will exhibit at the 7th Annual Congress of the German Knee Society (DKG), held in Munich (Holiday Inn City Centre), Germany, on November 23-24. As previously announced, Dr. med. Johannes Holz (Orthocentrum Hamburg) will present the clinical results from patients treated with the Episealer® knee implant and Priv.-Doz. Dr. Clemens Kösters (Maria-Josef-Hospital, Greven) will present a 2-year follow-up of his patients treated with the Episealer® knee implant.
For full program, see http://deutsche-kniegesellschaft.de/2018-2/. For an overview of the industry conferences attended by Episurf Medical, see link. (www.episurf.com/healthcare-professionals/conferences).
For more information, please contact:
Pål Ryfors, CEO, Episurf Medical
Tel:+46 (0) 709 62 36 69
About Episurf Medical
Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and personalised treatment alternatives. Episurf Medical’s Episealer® personalised implants and Epiguide® surgical drill guides are developed for treating localized cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.